NASDAQ · Healthcare · Biotechnology
Cassava Sciences, Inc.
SAVA
Cassava Sciences, Inc. CEO Richard Jon Barry · Market cap $94.4M.
$1.96
-0.04 · -1.76%
52w hi $4.9852w lo $1.15
Off 52w high 60.7%
0
LOW
Current InsiderScore
Corp · 90d
0
0 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
5
0 strong · 5 notable
Analyst consensus
Strong Buy
—
Section 01
Recent Form 4 filings
5 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Nov 20 | Richard Barry | President & CEO | Buy | 150,000 | $2.76 | +$414K | 65 |
| Nov 19 | Richard Barry | President & CEO | Buy | 73,385 | $2.75 | +$202K | 65 |
| Sep 30 | Robert Christopher Cook | Chief Operating & Legal Office | Buy | 13,725 | $2.91 | +$40K | 64 |
| Sep 19 | Richard Barry | President & CEO | Buy | 46,908 | $2.29 | +$107K | 62 |
| Sep 18 | Richard Barry | President & CEO | Buy | 185,233 | $2.24 | +$415K | 69 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay